AL
GSK icon

Aspiriant LLC’s GSK GSK Stock Holding History

Aspiriant LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469K Buy
8,494
+309
+4% +$16.7K 0.01% 228
2025
Q4 		$401K Buy
8,185
+185
+2% +$8.63K 0.01% 240
2025
Q3 		$345K Sell
8,000
-119
-1% -$4.65K 0.01% 234
2025
Q2 		$312K Sell
8,119
-122
-1% -$4.66K 0.01% 246
2025
Q1 		$319K Buy
+8,241
New +$302K 0.01% 230
2020
Q4 		– Sell
-4,960
Closed -$233K – 213
2020
Q3 		$233K Buy
+4,960
New +$249K 0.02% 198
2018
Q2 		– Sell
-5,040
Closed -$246K – 253
2018
Q1 		$246K Buy
+5,040
New +$235K 0.02% 212

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aspiriant LLC's GSK Position: Q1 2026 in Review

Aspiriant LLC increased its GSK (GSK) stake by 3.8% in Q1 2026, buying an estimated $16.7K and bringing the position to 8,494 shares worth $469K. The position accounts for 0.01% of the portfolio, ranked #228.

Aspiriant LLC first reported a position in GSK in Q1 2018 and has held it in 7 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Aspiriant LLC held 8,494 shares of GSK worth $469K as of Q1 2026.
  • Aspiriant LLC bought 309 GSK shares in Q1 2026, an estimated $16.7K.
  • GSK made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #228 holding.
  • Aspiriant LLC first reported a position in GSK in Q1 2018 and has held it in 7 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.